Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor.

Molecular cancer therapeutics - 1 Feb 2006

Ostapkowicz Anna, Inai Kunihiro, Smith Leia, Kreda Silvia, Spychala Jozef

Abstract excerpt

Recently, we have found dramatic overexpression of ecto-5'-nucleotidase (or CD73), a glycosylphosphatidylinositol-anchored component of lipid rafts, in estrogen receptor-negative [ER-] breast cancer cell lines and in clinical samples. To find out whether there is a more general shift in expression profile of membrane proteins, we undertook an investigation on the expression of selected membrane and cytoskeletal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytoskeletal Proteins
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histone Deacetylase Inhibitors

Share to Hydroxamic Acids

Share to Intracellular Signaling Peptides and Proteins

Share to Membrane Microdomains

Share to Neoplasm Invasiveness

Share to Receptors, Estrogen

Source

Identifiers

PMID: 16505096
DOI: 10.1158/1535-7163.MCT-05-0226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor.PMID 16505096Read ↗

Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.Semantic proximity Read ↗

ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.Semantic proximity Read ↗

Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer CellsSemantic proximity Read ↗

Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.Semantic proximity Read ↗

Quantitative Proteomics and Transcriptomics Addressing the Estrogen Receptor Subtype-mediated Effects in T47D Breast Cancer Cells Exposed to the Phytoestrogen GenisteinSemantic proximity Read ↗

Altered adhesions in ras-transformed breast epithelial cells.Semantic proximity Read ↗

Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme.Semantic proximity Read ↗

Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.Semantic proximity Read ↗

Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumorsSemantic proximity Read ↗

Modification of gene expression induced by siRNA targeting of estrogen receptor α in MCF7 human breast cancer cellsSemantic proximity Read ↗

Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton.Semantic proximity Read ↗

Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.